9 October 2023
Blue Star Capital plc
("Blue Star" or the "Company")
Directorate Change
Blue Star Capital plc (AIM: BLU), the investing company with a focus on esports, payments, technology and its applications within media and gaming, announces that Brian Rowbotham, a director of the Company, has stepped down from the board of the Company with immediate effect due to reasons of health.
The Company will start the process of looking for a replacement non-executive director immediately.
Tony Fabrizi, Executive Chairman of Blue Star Capital said that: "It has been a pleasure working with Brian who has supported the Company since early 2021. We are sorry to see Brian step down and wish him very well for the future."
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales.
The Directors of the Company are responsible for the release of this announcement.
For further information, please contact:
| Blue Star Capital plc | +44 (0) 777 178 2434 |
| Tony Fabrizi | |
| | |
| Cairn Financial Advisers LLP | +44 (0) 20 7213 0880 |
| (Nominated Adviser & Broker) | |
| Jo Turner / Liam Murray | |
| | |
About Blue Star
Blue Star is an investing company with a focus on new technologies. Blue Star's investments include SatoshiPay Limited, an incubator and service provider to de-fi businesses using blockchain technology; 4 early-stage to mid-level esports companies, including Guild eSports plc, a global esports business headquartered in London and Dynasty Gaming & Media Pte. Ltd., whose B2B white label platform is a full-stack gaming ecosystem; and Sthaler Limited, an identity and payments technology business which enables a consumer to identify themselves and pay using just their finger.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
